These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 16277203)
21. [Effect of mexidol on clinical and biochemical parameters of perinatal hypoxia in newborn children]. Levitina EV Eksp Klin Farmakol; 2001; 64(5):34-6. PubMed ID: 11764497 [TBL] [Abstract][Full Text] [Related]
22. [Possibilities of antioxidant therapy for asthenia and cognitive deficit in elderly patients with chronic brain ischemia]. Duma SN Ter Arkh; 2013; 85(12):100-5. PubMed ID: 24640678 [TBL] [Abstract][Full Text] [Related]
23. [Results of a cohort single-center randomized study of the modulating effect of the drug Mexidol in the rehabilitation of patients who suffered acute cerebral insufficiency]. Belkin AA; Belkin VA; Vasilchenko IE; Pinchuk EA Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(4):108-117. PubMed ID: 38676685 [TBL] [Abstract][Full Text] [Related]
24. [Effect of alpha-lipoic acid and mexidol on neuro- and the affective status in patients at early stages of diabetic foot syndrome]. Volchegorskiĭ IA; Alekseev MN; Volchegorskaia MI; Rassokhina LM Klin Med (Mosk); 2008; 86(10):52-9. PubMed ID: 19069461 [TBL] [Abstract][Full Text] [Related]
25. The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and alpha-tocopherol. Parkinson Study Group. LeWitt P; Oakes D; Cui L Mov Disord; 1997 Mar; 12(2):183-9. PubMed ID: 9087976 [TBL] [Abstract][Full Text] [Related]
26. [Effects of emoxipine, reamberine and mexidol on neuropathic symptoms and a systolic function of the left ventricular myocardium in patients with diabetes mellitus and diabetic foot syndrome]. Volchegorskiĭ IA; Moskvicheva MG; Chashchina EN Ter Arkh; 2005; 77(10):10-5. PubMed ID: 16320677 [TBL] [Abstract][Full Text] [Related]
27. [Effect of hydroxymethylethylpyridine succinate on the cardiac electrophysiological and hemodynamic parameters during experimental thoracotomy and acute myocardial ischemia]. Kotliarov AA; Smirnov LD Eksp Klin Farmakol; 2004; 67(3):14-7. PubMed ID: 15341060 [TBL] [Abstract][Full Text] [Related]
28. [The neuroprotective therapy of outpatient treatment of chronic cerebral ischemia]. Berezhnaya SV; Yakupov EZ Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(6):48-52. PubMed ID: 26356397 [TBL] [Abstract][Full Text] [Related]
29. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment]. Jost WH; Klasser M; Reichmann H Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504 [TBL] [Abstract][Full Text] [Related]
32. [Effectiveness of mexidol in acute pancreatitis]. Ivanov IuV; Chudnykh SM; Mozgalin AG Klin Med (Mosk); 2002; 80(9):44-6. PubMed ID: 12416225 [TBL] [Abstract][Full Text] [Related]
33. [Efficacy of emoxipine and mexidol in patients with chronic disorders of the digestive system and atherosclerosis of the abdominal aorta]. Dolgushina AI Eksp Klin Farmakol; 2011; 74(12):11-4. PubMed ID: 22379875 [TBL] [Abstract][Full Text] [Related]
34. A randomized, double-blind, controlled trial of add-on therapy in moderate-to-severe Parkinson's disease. Zhao S; Cheng R; Zheng J; Li Q; Wang J; Fan W; Zhang L; Zhang Y; Li H; Liu S Parkinsonism Relat Disord; 2015 Oct; 21(10):1214-8. PubMed ID: 26342560 [TBL] [Abstract][Full Text] [Related]
35. [Neurometabolic therapy in secondary prevention of stroke]. Koval'chuk VV Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(3):24-8. PubMed ID: 24781222 [TBL] [Abstract][Full Text] [Related]
36. A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes. Rascol O; Fitzer-Attas CJ; Hauser R; Jankovic J; Lang A; Langston JW; Melamed E; Poewe W; Stocchi F; Tolosa E; Eyal E; Weiss YM; Olanow CW Lancet Neurol; 2011 May; 10(5):415-23. PubMed ID: 21482191 [TBL] [Abstract][Full Text] [Related]
38. [The study of the efficacy and safety of Mexidol and Mexidol Forte 250 in patients with chronic cerebral ischemia]. Kutashov VA; Ulyanova OV Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(12. Vyp. 2):89-92. PubMed ID: 32207723 [TBL] [Abstract][Full Text] [Related]
39. [An analysis of mexidol efficacy in the complex treatment of patients with ischemic stroke]. Lutskiĭ MA Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(4 Suppl 2):57-9. PubMed ID: 20740717 [No Abstract] [Full Text] [Related]